Atomwise
About Atomwise
Atomwise is a pioneering healthcare AI company that leverages deep learning and artificial intelligence (AI) to revolutionize small molecule drug discovery. Their core technology, AtomNet, is a patented deep convolutional neural network. This platform is trained on vast datasets, including millions of structure-activity data points and thousands of protein structures, to predict the bioactivity of small molecules in 3D with high speed and accuracy.
For physicians, Atomwise’s technology means a significant acceleration in the identification and development of potential new medicines. By rapidly screening billions of compounds in silico, AtomNet can pinpoint promising drug candidates and explore novel chemical spaces, including those for historically ‘undruggable’ targets. This approach aims to reduce the time and cost associated with traditional drug discovery, ultimately bringing new therapies to patients faster. Atomwise collaborates with pharmaceutical and agrochemical companies, academic institutions, and hospitals to advance research in diverse areas such as leukemia, Ebola, multiple sclerosis, and various rare diseases.
Focus Areas
Business Intelligence
| Key Investors | DCVC, B Capital Group, Monsanto Growth Ventures, Sanabil Investments, Tencent Holdings, Y Combinator, Dolby Family Ventures, AME Cloud Ventures, Khosla Ventures, Bill & Melinda Gates Foundation, Baidu Ventures, Section 32, SV Health Investors |
| Partnerships | Sanofi, Eli Lilly and Company, Bayer, Hansoh Pharmaceuticals, Bridge Biotherapeutics, StemoniX, Pfizer |
| Technology | AtomNet® (proprietary deep convolutional neural network), NVIDIA GPUs on AWS, WEKA data platform |
What Physicians Need to Know
For physicians, Atomwise's AI-powered drug discovery platform offers the potential for faster development of novel small molecule therapies, particularly for challenging or previously 'undruggable' targets. This could lead to a broader range of treatment options and potentially first-in-class or best-in-class medicines across various therapeutic areas, including oncology, metabolic disorders, neurodegenerative diseases, and infectious diseases. The technology aims to reduce the time and cost associated with traditional drug discovery, ultimately accelerating the availability of new treatments for patients.
Atomwise's core product, AtomNetu00ae, is a proprietary deep-learning platform for structure-based virtual screening and small-molecule design at massive scale. It operates as an upstream R&D engine, integrating into existing project workflows for pharmaceutical, biotechnology, and academic R&D teams. Their technology stack includes SciPy, Unpkg, oEmbed, Hammer.js, Microsoft, DocuSign, PHP, and Python, and they leverage NVIDIA GPUs on AWS with the WEKA data platform for supercomputing-scale resources.
What the Web Says
Atomwise is generally viewed as a pioneering company in AI-driven drug discovery, leveraging deep learning to accelerate the identification of potential drug candidates. While praised for its innovative technology and scientific contributions, some employer reviews highlight challenges related to management, work-life balance, and internal communication.
Overall: MixedStrengths
- Innovative AI technology for drug discovery (AtomNet)
- Strong scientific foundation and research focus
- Potential to significantly accelerate drug development
- Collaborative and intelligent colleagues
- Meaningful work with a positive impact on health
- Good benefits package (according to some reviews)
Limitations
- Challenges with management and leadership communication
- Work-life balance can be an issue due to demanding environment
- Lack of clear career progression paths for some roles
- Internal processes and organization could be improved
- High pressure environment due to startup nature and ambitious goals
- Compensation not always competitive for all positions
Based on reviews from: Glassdoor, Reddit, Biotech industry news and articles, Healthcare IT review sites (general mentions of AI in drug discovery)
Last updated: 2026-10-07
Videos
News, demos, and interviews about Atomwise.
Videos load interactively. If none appear, search YouTube for Atomwise →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Atomwise.
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie (avie.me) is a healthcare AI company that focuses on providing a next-generation, whole-person health approach, bridging the gap between clinical and holistic care. The company connects individuals with providers and clinicians who can support their unique physical, emotional, cognitive, and logistical needs. Avie emphasizes fusing physical and mental best practices to enhance overall health, […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]